Azithromycin and Roxithromycin Define a New Family of Senolytic Drugs That Target Senescent Human Fibroblasts

    November 2018 in “ Aging
    Béla Ózsvári, John R. Nuttall, Federica Sotgia, Michael P. Lisanti
    Studysummary This study identified Azithromycin and Roxithromycin as novel senolytic antibiotics that effectively target and reduce senescent human fibroblast cells.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results